Home Compare BF-B vs BMY
Stock Comparison · Single-driver result

Brown-Forman vs Bristol-Myers Squibb Company: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Brown-Forman carrying a narrow edge on stability. Bristol-Myers Squibb Company still leads on growth and stability, which keeps the comparison from looking entirely one-sided. The market setup is currently leaning toward Bristol-Myers Squibb Company, which does not confirm the structural lead. That leaves a split case: the structural lead stays with Brown-Forman, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The page question resolves through stability, where Bristol-Myers Squibb Company holds the stronger read even though the broader score still favours Brown-Forman Corporation.

Trajectory Similarity
0.66
Moderately similar
Peer-set rank: #25
within Brown-Forman Corporation's functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

The clearest structural overlap shows up in capital structure and revenue growth trajectory.

Similarity drivers
capital structurerevenue growth trajectory
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
BF-B
Brown-Forman Corporation
62
Peer-Score
Signal qualityMedium
vs
BMY
Bristol-Myers Squibb Company
61
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in stability.

Dimension spread: BF-B vs BMY Profitability 76 38 Stability 15 56 Valuation 86 86 Growth 50 62 BF-B BMY
Gap Ranking
#1 Stability +41
#2 Profitability +38
#3 Growth +12
#4 Valuation
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BF-B and BMY Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BF-BBMY Relative valuation Structural strength

The setup remains mixed because the stronger profile and the more supportive price setup do not sit on the same side.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
Bristol-Myers Squibb Company sits in the stronger part of the group on stability, while Brown-Forman Corporation is closer to mid-pack.
Profitability
Brown-Forman Corporation ranks near the top of the group on profitability; Bristol-Myers Squibb Company sits in the weaker half.
Stability — Dominant Gap
BF-B
15
BMY
56
Gap+41in favour of BMY

The stability gap is very wide, with the stronger side looking materially steadier through time.

What keeps the gap from being one-sided

Earnings growth also leans the other way, which keeps the score lead from reading as a full growth sweep.

What this means for the comparison

Stability points one way, even though the overall score still points the other way.

Explore full peer positioning in AssetNext

Break down the BF-B vs BMY comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how BF-B and BMY each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.